These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 33556413)
21. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia. Assmann G; Kannenberg F; Ramey DR; Musliner TA; Gutkin SW; Veltri EP Curr Med Res Opin; 2008 Jan; 24(1):249-59. PubMed ID: 18053317 [TBL] [Abstract][Full Text] [Related]
22. Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial. Bonilha I; Gomes ÉIL; Carmo HRP; Breder I; Barreto J; Breder J; Munhoz DB; Carvalho LSF; Quinaglia T; Kimura-Medorima ST; Gossi CM; Zimetti F; Nadruz W; Zanotti I; Sposito AC; Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612917 [TBL] [Abstract][Full Text] [Related]
23. Effect of empagliflozin on cholesterol synthesis and absorption markers in patients with type 2 diabetes: Any role of DPP-4 inhibitors? Patoulias D; Papadopoulos C; Doumas M Int J Cardiol; 2021 May; 330():228. PubMed ID: 33626385 [No Abstract] [Full Text] [Related]
24. Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease. Okada K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S; Kimura K Atherosclerosis; 2012 Oct; 224(2):454-6. PubMed ID: 22892323 [TBL] [Abstract][Full Text] [Related]
25. Consumption of tall oil-derived phytosterols in a chocolate matrix significantly decreases plasma total and low-density lipoprotein-cholesterol levels. De Graaf J; De Sauvage Nolting PR; Van Dam M; Belsey EM; Kastelein JJ; Haydn Pritchard P; Stalenhoef AF Br J Nutr; 2002 Nov; 88(5):479-88. PubMed ID: 12425728 [TBL] [Abstract][Full Text] [Related]
26. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on sterol absorption in hypercholesterolemic subjects. Ntanios FY; Jones PJ; Frohlich JJ Metabolism; 1999 Jan; 48(1):68-73. PubMed ID: 9920147 [TBL] [Abstract][Full Text] [Related]
27. Visceral fat positively correlates with cholesterol synthesis in dyslipidaemic patients. Lupattelli G; Pirro M; Mannarino MR; Siepi D; Roscini AR; Schillaci G; Mannarino E Eur J Clin Invest; 2012 Feb; 42(2):164-70. PubMed ID: 21793822 [TBL] [Abstract][Full Text] [Related]
29. Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism. Briand F; Mayoux E; Brousseau E; Burr N; Urbain I; Costard C; Mark M; Sulpice T Diabetes; 2016 Jul; 65(7):2032-8. PubMed ID: 27207551 [TBL] [Abstract][Full Text] [Related]
30. Biological variation of β-sitosterol, campesterol, and lathosterol as cholesterol absorption and synthesis biomarkers. Wu AH; Ruan W; Todd J; Lynch KL Clin Chim Acta; 2014 Mar; 430():43-7. PubMed ID: 24394292 [TBL] [Abstract][Full Text] [Related]
31. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
32. Enhanced efficacy of sitostanol-containing versus sitostanol-free phytosterol mixtures in altering lipoprotein cholesterol levels and synthesis in rats. Ling WH; Jones PJ Atherosclerosis; 1995 Dec; 118(2):319-31. PubMed ID: 8770325 [TBL] [Abstract][Full Text] [Related]
33. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject. Ketomaki A; Gylling H; Miettinen TA J Lab Clin Med; 2004 Apr; 143(4):255-62. PubMed ID: 15085084 [TBL] [Abstract][Full Text] [Related]
34. Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus. Okada K; Yagyu H; Kotani K; Miyamoto M; Osuga J; Nagasaka S; Ishibashi S Endocr J; 2010; 57(10):903-8. PubMed ID: 20733267 [TBL] [Abstract][Full Text] [Related]
35. Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults. Brämswig S; Kerksiek A; Sudhop T; Luers C; Von Bergmann K; Berthold HK Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H704-16. PubMed ID: 11788421 [TBL] [Abstract][Full Text] [Related]
36. Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine. Thuluva SC; Igel M; Giesa U; Lütjohann D; Sudhop T; von Bergmann K Int J Clin Pharmacol Ther; 2005 Jul; 43(7):305-10. PubMed ID: 16035372 [TBL] [Abstract][Full Text] [Related]
37. Markers of cholesterol synthesis are elevated in adolescents and young adults with type 2 diabetes. Semova I; Levenson AE; Krawczyk J; Bullock K; Williams KA; Wadwa RP; Khoury PR; Kimball TR; Urbina EM; de Ferranti SD; Maahs DM; Dolan LM; Shah AS; Clish CB; Biddinger SB Pediatr Diabetes; 2020 Nov; 21(7):1126-1131. PubMed ID: 32738021 [TBL] [Abstract][Full Text] [Related]
38. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Miettinen TA; Tilvis RS; Kesäniemi YA Am J Epidemiol; 1990 Jan; 131(1):20-31. PubMed ID: 2293749 [TBL] [Abstract][Full Text] [Related]